CA2243984A1 - Variantes d'epissage de molecule d'adherence cellulaire neuronale - Google Patents

Variantes d'epissage de molecule d'adherence cellulaire neuronale Download PDF

Info

Publication number
CA2243984A1
CA2243984A1 CA002243984A CA2243984A CA2243984A1 CA 2243984 A1 CA2243984 A1 CA 2243984A1 CA 002243984 A CA002243984 A CA 002243984A CA 2243984 A CA2243984 A CA 2243984A CA 2243984 A1 CA2243984 A1 CA 2243984A1
Authority
CA
Canada
Prior art keywords
polypeptide
nrcamvar
pro
leu
val
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA002243984A
Other languages
English (en)
Inventor
Jonathan Alexander Terrett
Susan Jane Kenwrick
Bo Wang
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
SmithKline Beecham Ltd
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB9703011.8A external-priority patent/GB9703011D0/en
Application filed by Individual filed Critical Individual
Publication of CA2243984A1 publication Critical patent/CA2243984A1/fr
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/70503—Immunoglobulin superfamily
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Diabetes (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Obesity (AREA)
  • Engineering & Computer Science (AREA)
  • Hematology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Emergency Medicine (AREA)
  • Endocrinology (AREA)
  • Immunology (AREA)
  • Cell Biology (AREA)
  • Child & Adolescent Psychology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)

Abstract

L'invention concerne des polypeptides et des polynucléotides NrCAMvar, ainsi que des procédés de production des ces polypeptides par des techniques de recombinaison. L'invention concerne également des procédés d'utilisation desdits polypeptides et polynucléotides NrCAMvar dans la conception de protocoles destinés notamment au traitement du diabète, de l'obésité, et du cancer, ainsi que dans la conception de méthodes permettant de diagnostiquer ces maladies.
CA002243984A 1997-02-13 1998-02-12 Variantes d'epissage de molecule d'adherence cellulaire neuronale Abandoned CA2243984A1 (fr)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
GB9703011.8 1997-02-13
GBGB9703011.8A GB9703011D0 (en) 1997-02-13 1997-02-13 Novel compounds
EP97305485 1997-07-22
EP97305485.1 1997-07-22

Publications (1)

Publication Number Publication Date
CA2243984A1 true CA2243984A1 (fr) 1998-08-20

Family

ID=26147528

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002243984A Abandoned CA2243984A1 (fr) 1997-02-13 1998-02-12 Variantes d'epissage de molecule d'adherence cellulaire neuronale

Country Status (4)

Country Link
EP (1) EP0910641A1 (fr)
JP (2) JPH11507845A (fr)
CA (1) CA2243984A1 (fr)
WO (1) WO1998036062A1 (fr)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7034132B2 (en) 2001-06-04 2006-04-25 Anderson David W Therapeutic polypeptides, nucleic acids encoding same, and methods of use
EP1259819A2 (fr) * 2000-02-24 2002-11-27 Oxford GlycoSciences (UK) Limited Diagnostic de maladies affectives bipolaires (bad) et de depressions unipolaires
AU2001249835A1 (en) * 2000-04-03 2001-10-15 Oxford Glycosciences (Uk) Ltd. Diagnosis and treatment of alzheimer's disease
US6852874B2 (en) * 2000-10-02 2005-02-08 The Scripps Research Institute Second cycle asymmetric dihydroxylation reaction
WO2003000021A2 (fr) * 2001-06-22 2003-01-03 Biogen, Inc. Acides nucleiques et polypeptides pancam
RS53782B1 (sr) * 2008-10-01 2015-06-30 Immatics Biotechnologies Gmbh Preparati tumor-asociranih peptida i odgovarajuća antikancerska vakcina za tretman glioblastoma (gbm) i drugih kancera

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0821591A1 (fr) * 1995-04-19 1998-02-04 Acorda Therapeutics Modulateurs de la croissance de l'axone et des dendrites du systeme nerveux central, compositions, cellules et procedes dans lesquels ils sont mis en uvre et utilises

Also Published As

Publication number Publication date
JPH11507845A (ja) 1999-07-13
EP0910641A1 (fr) 1999-04-28
WO1998036062A1 (fr) 1998-08-20
JP2002300892A (ja) 2002-10-15

Similar Documents

Publication Publication Date Title
US6319688B1 (en) Polynucleotide encoding human sodium dependent phosphate transporter (IPT-1)
JPH10323194A (ja) Tnfの相同体tl5
JPH1198988A (ja) ヒト7膜貫通受容体をコードするcDNAクローンHEOAD54
US6232441B1 (en) PIGR-1, a member of immunoglobulin gene superfamily
JP2002199893A (ja) Gタンパク質共役型受容体hfiao41
JP2002186493A (ja) 新規なgタンパク質共役受容体h7tba62
JPH1084976A (ja) 新規ヒトg−蛋白質結合レセプター
JPH11235184A (ja) ヒト7回膜貫通受容体をコードするcDNAクローンHNEAA8 1
JPH1118786A (ja) 腫瘍壊死関連受容体tr7
EP0875572A2 (fr) CRFG-1a, cible et marqueur pour l'insuffisance rénale chronique
US6350446B1 (en) HAS2 splicing variant HOEFC11: a target in chronic renal failure, inflammatory diseases and myocardial ischemia
JPH1156375A (ja) エプスタイン・バーウイルスにより誘導されるgタンパク質共役受容体の新規なスプライシング変異体
EP0910641A1 (fr) Variantes d'epissage de molecule d'adherence cellulaire neuronale
EP0905238A2 (fr) Pigrl-1, appartenant au sous-ordre des immunoglobulines
WO1999046295A1 (fr) Gene homologue au gene b(2)gene de drosophile et proteine ypr015c de levure putative 26,5kd
WO1999049023A1 (fr) Element 2-21 de la famille des cytokines
US6919430B1 (en) Polypeptide—human galectin 15 and a polynucleotide encoding the same
JPH11206391A (ja) ヒトlig−1相同体(hlig−1)
JP2002238589A (ja) 慢性腎不全、アテローム性動脈硬化および繊維症の標的としての新規なsMAD3スプライス変異体
JPH11215989A (ja) 免疫グロブリン遺伝子スーパーファミリーのメンバー、pigr−2
WO1999021885A1 (fr) Gene transporteur 7 abc humain (habc7)
CA2220849A1 (fr) Homologue de pelota humain
US6994996B1 (en) Polypeptide, human vacuolar H+ -ATPase C subunit 42 and polynucleotide encoding it
WO1999022006A1 (fr) Cblafc02: sous-unite de h(+)-atpase vacuolaire
JP2002223778A (ja) 慢性腎不全の標的およびマーカーであるcrfg−1

Legal Events

Date Code Title Description
FZDE Dead